Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Immunocellular Therapeutics

Immunocellular Therapeutics
1987 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
IMUC STOCK SYMBOL
$0.05 SHARE PRICE (As of Friday Closing)
Description

ImmunoCellular Therapeutics Ltd is a US-based clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme (GBM), which is a lethal type of brain cancer. It develops Immunotherapies for treating cancer in which a patient's own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 23622 Calabasas Road
  • Suite 300
  • Calabasas, CA 91302
  • United States

+1 (818) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Immunocellular Therapeutics’s full profile, request a free trial.

Immunocellular Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.01 - $0.05 $1.82M $0.04 134K

Immunocellular Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 5,871 5,116 (5,895) 7,652
Revenue 0 0 0 0
EBITDA (5,650) (13,386) (20,723) (12,641)
Net Income (5,664) (14,312) (22,086) (12,791)
Total Assets 3,829 7,009 16,890 30,082
Total Debt 574 1,959
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Immunocellular Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Immunocellular Therapeutics‘s full profile, request access.

Request full access to PitchBook

Immunocellular Therapeutics Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celgene Pending Transaction (M&A) Summit, NJ 0000 000.00 000000&0 000.00
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000000000 0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
000000000 Private Equity-Backed Gaithersburg, MD 000.00 0000000 0000 000.00
000000 00000000000 Venture Capital-Backed San Diego, CA 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Immunocellular Therapeutics Executive Team (6)

Name Title Board
Seat
Contact
Info
Gary Titus Chairman & Board Member

5 Former Executives

You’re viewing 1 of 6 executives. Get the full list »

Immunocellular Therapeutics Board Members (17)

Name Representing Role Since Contact
Info
0000 00000 Immunocellular Therapeutics Chairman & Board Member 000 0000
0000 00 00 Immunocellular Therapeutics Board Member 000 0000
00000 0000000 00.0 Self Board Member 000 0000

14 Former Board Members

You’re viewing 3 of 17 board members. Get the full list »